Macrophage-targeted Sod2 mRNA nanotherapy reduces mitochondrial oxidative stress and stabilizes vulnerable atherosclerotic plaques
{{output}}
Background: Mitochondrial oxidative stress contributes to atherosclerotic plaque progression and instability, yet no therapies directly target mitochondrial redox imbalance. Superoxide dismutase 2 (SOD2), the primary mitochondria... ...
